QA: Sarepta Therapeutics Inc. in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000873303_2021_Sarepta_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0000873303, Sarepta Therapeutics Inc.

  xvar xval
0 AssetsCurrent 2,485,196,000
1 IntangibleAssetsNetIncludingGoodwill 13,628,000
2 PropertyPlantAndEquipmentNet 190,430,000
3 remainder_Assets 295,464,000
4 LiabilitiesCurrent 416,026,000
5 LiabilitiesNoncurrent 763,640,000
6 remainder_Liabilities 1,043,293,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 317,875,000
9 ResearchAndDevelopmentExpense 722,343,000
10 remainder_Expenses 65,107,000
11 remainder_Revenues 540,099,000
12 remainder_NetIncome 11,098,000
13 remainder_ComprehensiveNetIncome -47,000
  yvar yval
0 Assets 2,984,718,000
1 Liabilities 2,222,959,000
2 Expenses 1,105,325,000
3 Revenues 540,099,000
4 StockholdersEquity 761,759,000
5 NetIncome -554,128,000
6 ComprehensiveNetIncome -554,151,500
7 BaseVar 3,432,123,000
8 EconomicCapitalRatio 0.290

Edgar->Model Mapping

Feature Distribution

Change over Time